investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Tumor Metabolism
David L Woodland
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David L Woodland
Keystone Symposia On Molecular and Cellular Biology
Silverthorne, United States
Collaborator from Whistler Conference Centre
Whistler Conference Centre
Whistler, Canada
Related projects
Paul B. Jacobsen
Behavioral Oncology Education & Career Development
All cancers but non-melanoma skin cancer
Alan Anderson
Inducible metabolism of xenochemicals and endogenous toxic compounds: Nuclear receptors and the CYP2B paradigm
All cancers but non-melanoma skin cancer
Nicholas Restifo
Building on the Success of the Adoptive Immunotherapy of Cancer
All cancers but non-melanoma skin cancer
Xiaole Shirley Liu
Developing Informatics Technologies to Model Cancer Gene Regulation
All cancers but non-melanoma skin cancer
Yi Tang
Characterization and Engineering of Fungal Megasynthases
All cancers but non-melanoma skin cancer
Gary M Wessel
Post-translational Regulation of Germline Determinants
All cancers but non-melanoma skin cancer
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer
Hiroaki Mitsuya
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
All cancers but non-melanoma skin cancer
Stuart Keith Calderwood
Complex Role of HSF1 in Breast Cancer
All cancers but non-melanoma skin cancer